Anika Therapeutics (ANIK) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.48 -1.96%
EPS Growth %: -25.0%
Financial Fact:
Product revenue: 25.78M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -25.0%
Financial Fact:
Product revenue: 25.78M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $27.8 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
- Allstate (ALL) call put ratio 2.8 calls to 1 put with a focus on January 180 and 230 calls
- 2G Energy receives 275 MW order from Energy Vault for U.S. data centers
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
